基于地理探测器的宁夏贺兰山植被覆盖度时空分异及驱动因子

监测区域植被覆盖变化并分析其驱动因子,有利于实现生态环境的可持续发展。本研究以1989—2021年Landsat 5/8遥感影像为数据源,利用像元二分模型获取宁夏贺兰山植被覆盖度,基于地理探测器量化了环境和人为等10个因子对其时空分布的影响。结果表明: 1989—2021年间,宁夏贺兰山平均植被覆盖度为35.8%,时间尺度上总体呈增加趋势,平均增幅为0.043·(10 a)^-1,空间尺度上呈现从西南向东北递减的分布特征;研究区58.1%的区域植被覆盖度未来将持续性改善,但仍有30.7%的植被存在退化的潜在风险。降水是影响植被分布的主要环境因子,与单因子相比,环境因子和人为因子的交互作用对植被覆盖度的解释力更强,降水与其他因子的交互作用处于主导作用。     

金钱松群落优势种群种间联结及群落稳定性研究

种间联结反映了植物群落中的种间关系和群落稳定程度,对群落恢复和目标物种的保护具有重要意义.为了解金钱松群落的种间关系及群落稳定性,采用方差比率法(VR)、x2检验、联结系数(AC)、共同出现百分率(PC)、Pearson相关系数、Spearman秩相关系数以及M.Godron稳定性测定等数量分析方法,对浙江长兴金钱松群...     

中国小头蓟马属二新种：缨翅目：蓟马科

西方记述了中国小头蓟马属Ｍｉｃｒｏｅｐｈａｌｏｔｈｒｉｐｓ２新种－中华小头蓟马Ｍ．ｃｈｉｎｅｎｓｉｓｓｐ．ｎｏｖ。     

海南野生稻资源调查收集与保护

为了加强海南野生稻资源的保护和研究利用,2002—2013年对海南省18市(县)野生稻资源进行野外调查、资源收集和原、异位保护。初步查明,目前在全省15个市(县)发现154个野生稻自然居群,其中普通野生稻136个、疣粒野生稻11个、药用野生稻7个。收集到野生稻居群87个,其中普通野生稻80个、疣粒野生稻4个、药用野生稻3个,总共2900余份野生稻种茎,经繁殖和编目后妥善保存于海南省农业科学院试验基地的热带野生稻异位保存圃中,并参照农业行业标准-农业野生植物原生境保护点建设技术规范,分别在文昌、琼海、儋州、万宁、陵水和保亭等县(市)建立了6个野生稻原生境保护点,其中普通野生稻4个,疣粒野生稻1个,药用野生稻1个。根据调查结果,对海南野生稻濒危状况及其根源进行了分析,提出了海南野生稻保护相关建议。     

血塞通体内中和内毒素作用的试验研究

目的:探讨血塞通体内中和内毒素的作用.方法:健康大耳白兔24只,随机分为正常对照组、内毒素组、血塞通干预组,每组8只.内毒素组经耳缘静脉静推LPS(1mg/kg),12h后再由耳缘静脉注射一次LPS(1mg/kg),复制SIRS/MODS动物模型;对照组耳缘静脉静推等量生理盐水;血塞通干预组于Oh,12h经耳缘静脉推注LPS(Img/kg)并于第一次注入内毒素后6h,12h,18h静推血塞通(50mg/kg).于24h时间点测定各组动物血清肿瘤坏死因子-α(TNF-α)、白细胞介素-(IL-1)、白细胞介素-8(IL-8)、血小板活化因子(PAF).光镜下观察各组动物脏器病理学变化.结果:血塞通干预组与内毒素组相比,IL-1、IL-8、PAF、TNF-α均较内毒素组有不同程度降低.血塞通干预组脏器损伤组织学改变较内毒素组明显减轻.结论:血塞通在体内能明显中和内毒素的作用,为防治SIRS/MODS提供了实验依据.     

2000～2008年长白山地区植被覆盖变化特征

利用2000～2008年250 m分辨率MODIS/NDVI数据,结合谐波分析、影像处理和多种统计方法分析长白山地区的植被覆盖年内和年际变化特征,并结合区划图和植被类型图对不同区域和不同植被类型的植被覆盖变化进行分析.结果显示:近9年长白山地区覆盖总体呈上升趋势,其中春季植被覆盖略有下降,夏季植被覆盖变化不大,而秋季植被覆盖显著上升;和龙林业局、露水河林业局和长白山自然保护区的植被覆盖较好,而朝鲜一侧、泉阳林业局和长白林业局的植被覆盖较差;针叶林、阔叶林和针阔混交林的植被覆盖要高于荒草地、沼泽地、高山岳桦林和高山苔原,但后几种植被类型的植被覆盖增长趋势明显.     

Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells

Background

Long noncoding RNAs (lncRNAs) are related to different biological processes in non-small cell lung cancer (NSCLC). However, the possible molecular mechanisms underlying the effects of the long noncoding RNA HOXA11-AS (HOXA11 antisense RNA) in NSCLC are unknown.

Methods

HOXA11-AS was knocked down in the NSCLC A549 cell line and a high throughput microarray assay was applied to detect changes in the gene profiles of the A549 cells. Bioinformatics analyses (gene ontology (GO), pathway, Kyoto Encyclopedia of Genes and Genomes (KEGG), and network analyses) were performed to investigate the potential pathways and networks of the differentially expressed genes. The molecular signatures database (MSigDB) was used to display the expression profiles of these differentially expressed genes. Furthermore, the relationships between the HOXA11-AS, de-regulated genes and clinical NSCLC parameters were verified by using NSCLC patient information from The Cancer Genome Atlas (TCGA) database. In addition, the relationship between HOXA11-AS expression and clinical diagnostic value was analyzed by receiver operating characteristic (ROC) curve.

Results

Among the differentially expressed genes, 277 and 80 genes were upregulated and downregulated in NSCLC, respectively (fold change ≥2.0, P < 0.05 and false discovery rate (FDR) < 0.05). According to the degree of the fold change, six upregulated and three downregulated genes were selected for further investigation. Only four genes (RSPO3, ADAMTS8, DMBT1, and DOCK8) were reported to be related with the development or progression of NSCLC based on a PubMed search. Among all possible pathways, three pathways (the PI3K-Akt, TGF-beta and Hippo signaling pathways) were the most likely to be involved in NSCLC development and progression. Furthermore, we found that HOXA11-AS was highly expressed in both lung adenocarcinoma and squamous cell carcinoma based on TCGA database. The ROC curve showed that the area under curve (AUC) of HOXA11-AS was 0.727 (95% CI 0.663–0.790) for lung adenocarcinoma and 0.933 (95% CI 0.906–0.960) for squamous cell carcinoma patients. Additionally, the original data from TCGA verified that ADAMTS8, DMBT1 and DOCK8 were downregulated in both lung adenocarcinoma and squamous cell carcinoma, whereas RSPO3 expression was upregulated in lung adenocarcinoma and downregulated in lung squamous cell carcinoma. For the other five genes (STMN2, SPINK6, TUSC3, LOC100128054, and C8orf22), we found that STMN2, TUSC3 and C8orf22 were upregulated in squamous cell carcinoma and that STMN2 and USC3 were upregulated in lung adenocarcinoma. Furthermore, we compared the correlation between HOXA11-AS and de-regulated genes in NSCLC based on TCGA. The results showed that the HOXA11-AS expression was negatively correlated with DOCK8 in squamous cell carcinoma (r = ?0.124, P = 0.048) and lung adenocarcinoma (r = ?0.176, P = 0.005). In addition, RSPO3, ADAMTS8 and DOCK8 were related to overall survival and disease-free survival (all P < 0.05) of lung adenocarcinoma patients in TCGA.

Conclusions

Our results showed that the gene profiles were significantly changed after HOXA11-AS knock-down in NSCLC cells. We speculated that HOXA11-AS may play an important role in NSCLC development and progression by regulating the expression of various pathways and genes, especially DOCK8 and TGF-beta pathway. However, the exact mechanism should be verified by functional experiments.

     

丙戊酸影响神经干细胞体外分化的量效和时效关系

目的：研究丙戊酸（VPA）浓度和干预时间对神经干细胞（NSCs）体外分化的影响。方法：以不同浓度的VPA（0.1、0.3、0.5、0.75和1.0mmol/L）处理原代培养的神经干细胞,以NB培养基组做对照,分别于神经干细胞分化后3天、7天、10天和14天用免疫荧光双标鉴定并计数微管蛋白-Ⅲ（β-tubllin III）和胶质原纤维酸性蛋白（GFAP）阳性细胞的比例,并作统计学分析。结果：同一时相点组间比较,3天时各组中神经元分化比例无显著差异;7天时不同浓度VPA组与对照组分化神经元比例开始呈现差异;10天时这种差异继续增大,0.75 mmol/L VPA组中神经元比例为82.15±0.93%;14天时保持这种差异;但各时相点1.0 mmol/L VPA组与0.75 mmol/L VPA组神经元分化的比例无显著差异。不同时相点组内比较发现,3-10天内随着时间的延长,各组神经元分化的比例显著增加,但14天时神经元分化的比例较10天无显著变化。结论：0.75mmol/L VPA在10天时促神经干细胞向神经元分化的作用最佳。     

180份玉米自交系亲缘关系的分子评价

利用覆盖玉米全基因组的22对SSR引物,对180份玉米自交系的亲缘关系进行分子评价.结果显示:22对SSR引物共检测到129个等位基因,每一位点平均等位基因数5.9,变幅2～13;平均基因多样性指数和平均多态性信息含量分别为0.583和0.528.基于模型的群体结构分析将所有材料分为5个类群,与国内自交系划分的杂种优势...     

吉西他滨与吉非替尼联合顺铂治疗西北区非小细胞肺癌患者的疗效分析

目的:比较吉西他滨与吉非替尼联合顺铂治疗非小细胞肺癌的临床有效性及安全性。方法:80例非小细胞肺癌患者根据入院顺序平分为治疗组与对照组各40例,治疗组采用吉西他滨联合顺铂治疗,对照组采用吉非替尼联合顺铂治疗,对比观察两组治疗效果及存活时间。结果:经过治疗后,治疗组无完全缓解患(CR)病例,部分缓解(PR)16例,有效率(RR)40.0%;对照组无完全缓解(CR)病例,部分缓解(PR)8例,有效率(RR)20.0%。治疗组的治疗有效率明显高于对照组,两组差异有显着性意义(P<0.05)。治疗组1年生存率为50.0%(20/40),对照组1年生存率为45.0%(18/40),两组1年生存率比较无统计学差异(P>005)。治疗组在治疗中有20例患者出现不同程度的不良反应,治疗组出现23例不同程度的不良反应。两组不良反应主要为皮疹、腹泻、转氨酶升高、皮肤水泡等。两组总的不良反应发生率与各个单项不良反应发生率相比无显着性差异,具有可比性(P>0.05)。结论:吉西他滨联合顺铂治疗非小细胞肺癌的临床有能取得更好的近期治疗效果,同时无明显不良反应,但不会提高1年生存率,值得推广应用。